by jhollister | Nov 1, 2018 | Home Page, News
Clinical trial tests safety and dosing of NEO-201 antibody in patients with advanced cancer NIH 11/01/2018 Patients with advanced solid tumors may be eligible to participate in a new clinical trial at the NIH Clinical Center. Read Full Article Click...
by jhollister | Jan 8, 2018 | News
Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas View the Publication Click...
by Jen Hodson | Apr 2, 2017 | Home Page, News
Rockville, MD, April 2, 2017 – Precision-Biologics Inc. today announced an abstract reporting data on the company’s neo-antigen program has been accepted for an oral presentation at the upcoming 110th Annual Meeting of the American Association of...
by Jen Hodson | Nov 21, 2016 | Home Page, News, Presentations
Embed from Getty Images Clinical investigators from Moffitt and Walter Reed Army Institute present data of first Phase II Neoepitope Antibody Immunotherapy Clinical Trial completed at John’s Hopkins, Duke and Moffitt as a potential new immunotherapy treatment for...
by Jen Hodson | Sep 29, 2016 | Events, News, Presentations
Dr. Philip Arlen to Speak at Biomarkers & Precision Medicine USA Congress – 3-4 October 2016, San Diego, USA For more information Click...
by Jen Hodson | Sep 29, 2016 | Events, News, Presentations
Dr. Philip Arlen to Speak at Immune Profiling World Congress – 11-12 October 2016, Fairmont Rey Juan Carlos For more information Click...
